Endothelial Protection in Post COVID-19 Patients With Sulodexide

NCT05371925 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

206

Enrollment

OTHER

Sponsor class

Conditions

Post COVID-19
Endothelial Dysfunction
Thrombosis

Interventions

DRUG: Sulodexide

Sponsor

Centro Medico del Noroeste

Collaborators

[object Object]